Aspen Pharmacare Holdings Ltd (JSE:APN)
R 176.71 -2.86 (-1.59%) Market Cap: 78.50 Bil Enterprise Value: 102.62 Bil PE Ratio: 17.82 PB Ratio: 0.93 GF Score: 85/100

Full Year 2020 Aspen Pharmacare Holdings Ltd Earnings Call Transcript

Sep 10, 2020 / 06:30AM GMT
Release Date Price: R131.54 (-5.67%)
Michael Guy Attridge
Aspen Pharmacare Holdings Limited - Deputy Group Chief Executive, Finance Director & Executive Director

Good morning, ladies and gentlemen, and welcome to the Aspen 2020 results presentation. I've done over 40 of these presentations over the last 2 decades, and this is certainly the first one where I've had to come up in disguise. So that's got nothing to do with our results and everything to do with the world around us as we know. I'm going to start off the presentation with a financial review. And let me kick off by saying that it's been a very challenging time for all of us with the COVID-19 pandemic. Aspen is in a fortunate position as a company to be relevant in these times. But nonetheless, it has taken a great deal for us to keep operational. I'm very, very proud of all of our people who have managed to keep Aspen in full production and providing medicines around the world during these challenging times.

We're also extremely pleased with the performance that we've achieved, although this has been somewhat diluted by the effect of the pandemic. We had 4 medium-term

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot